Grifols, S.A. (GIKLY)
OTCMKTS · Delayed Price · Currency is USD
7.49
+0.45 (6.32%)
Jul 31, 2025, 12:47 PM EDT
Accolade Market Cap
Grifols has a market cap or net worth of $9.16 billion as of August 1, 2025. Its market cap has increased by 46.89% in one year.
Market Cap
9.16B
Enterprise Value
21.62B
Revenue
8.74B
Ranking
n/a
PE Ratio
26.22
Stock Price
$7.49
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 931.51M to 9.16B, an increase of 883.22%. That is a compound annual growth rate of 12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 9.16B | 55.72% |
| Dec 31, 2024 | 5.88B | -42.36% |
| Dec 29, 2023 | 10.20B | 45.60% |
| Dec 30, 2022 | 7.01B | -36.73% |
| Dec 30, 2021 | 11.08B | -36.06% |
| Dec 31, 2020 | 17.32B | -17.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 415.24M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 349.54M |
| CytoDyn | 341.59M |